

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 9.89229426 |
| 2 | DNA deamination (GO:0045006) | 9.74964059 |
| 3 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 9.34191556 |
| 4 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 6.39767019 |
| 5 | positive regulation of osteoclast differentiation (GO:0045672) | 6.07477626 |
| 6 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 5.40068711 |
| 7 | myeloid dendritic cell differentiation (GO:0043011) | 5.34446440 |
| 8 | regulation of immunoglobulin secretion (GO:0051023) | 5.26896380 |
| 9 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 5.03564266 |
| 10 | cellular response to interleukin-15 (GO:0071350) | 4.95485659 |
| 11 | signal peptide processing (GO:0006465) | 4.87505893 |
| 12 | myeloid dendritic cell activation (GO:0001773) | 4.85996671 |
| 13 | response to interleukin-15 (GO:0070672) | 4.73424672 |
| 14 | positive regulation of defense response to virus by host (GO:0002230) | 4.61899576 |
| 15 | chaperone-mediated protein transport (GO:0072321) | 4.61336677 |
| 16 | positive regulation of transcription regulatory region DNA binding (GO:2000679) | 4.55279323 |
| 17 | pyrimidine nucleoside catabolic process (GO:0046135) | 4.53395208 |
| 18 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.50141714 |
| 19 | negative regulation of thymocyte apoptotic process (GO:0070244) | 4.42951116 |
| 20 | positive regulation of T cell cytokine production (GO:0002726) | 4.40972913 |
| 21 | negative regulation of viral genome replication (GO:0045071) | 4.34100229 |
| 22 | eosinophil chemotaxis (GO:0048245) | 4.33673215 |
| 23 | T-helper 1 type immune response (GO:0042088) | 4.14481128 |
| 24 | T cell migration (GO:0072678) | 4.06333732 |
| 25 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 4.05610221 |
| 26 | negative regulation by host of viral transcription (GO:0043922) | 3.88017596 |
| 27 | eosinophil migration (GO:0072677) | 3.87571545 |
| 28 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 3.63008015 |
| 29 | cytolysis (GO:0019835) | 3.50147010 |
| 30 | negative regulation of T cell apoptotic process (GO:0070233) | 3.46191979 |
| 31 | macrophage chemotaxis (GO:0048246) | 3.39453468 |
| 32 | regulation of viral genome replication (GO:0045069) | 3.38732137 |
| 33 | T cell apoptotic process (GO:0070231) | 3.35024917 |
| 34 | negative regulation of B cell proliferation (GO:0030889) | 3.34661375 |
| 35 | pyrimidine ribonucleoside metabolic process (GO:0046131) | 3.32934972 |
| 36 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.22465409 |
| 37 | negative regulation of viral process (GO:0048525) | 3.18195358 |
| 38 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.16115991 |
| 39 | DNA double-strand break processing (GO:0000729) | 3.15703053 |
| 40 | regulation of defense response to virus by host (GO:0050691) | 3.15151642 |
| 41 | NIK/NF-kappaB signaling (GO:0038061) | 3.14624434 |
| 42 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.13212916 |
| 43 | cellular response to interleukin-1 (GO:0071347) | 3.12641278 |
| 44 | lymphocyte chemotaxis (GO:0048247) | 3.11884137 |
| 45 | DNA demethylation (GO:0080111) | 3.10807784 |
| 46 | cytokine biosynthetic process (GO:0042089) | 3.07684258 |
| 47 | regulation of thymocyte apoptotic process (GO:0070243) | 3.04791267 |
| 48 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 3.03364909 |
| 49 | positive regulation of interleukin-1 secretion (GO:0050716) | 3.02595686 |
| 50 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.02373261 |
| 51 | positive regulation of myeloid leukocyte differentiation (GO:0002763) | 3.00145647 |
| 52 | lymphocyte apoptotic process (GO:0070227) | 2.99015212 |
| 53 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.98302597 |
| 54 | dendritic cell differentiation (GO:0097028) | 2.97963545 |
| 55 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.97405249 |
| 56 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.97364793 |
| 57 | regulation of regulatory T cell differentiation (GO:0045589) | 2.95069220 |
| 58 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.87645244 |
| 59 | pyrimidine-containing compound catabolic process (GO:0072529) | 2.86565040 |
| 60 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.86196434 |
| 61 | regulation of T cell cytokine production (GO:0002724) | 2.84652665 |
| 62 | negative regulation of viral transcription (GO:0032897) | 2.80097958 |
| 63 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.79694591 |
| 64 | response to interferon-beta (GO:0035456) | 2.78940565 |
| 65 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.76652964 |
| 66 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.74964316 |
| 67 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.74661179 |
| 68 | alpha-beta T cell differentiation (GO:0046632) | 2.73087107 |
| 69 | positive regulation of interleukin-2 production (GO:0032743) | 2.72830636 |
| 70 | negative regulation of B cell activation (GO:0050869) | 2.72485293 |
| 71 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.72371449 |
| 72 | regulation of interleukin-2 production (GO:0032663) | 2.72187602 |
| 73 | regulation of interleukin-1 secretion (GO:0050704) | 2.71226894 |
| 74 | regulation of T cell apoptotic process (GO:0070232) | 2.70152519 |
| 75 | response to acidic pH (GO:0010447) | 2.69756885 |
| 76 | negative regulation of interleukin-12 production (GO:0032695) | 2.69638675 |
| 77 | granulocyte activation (GO:0036230) | 2.69485974 |
| 78 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.68554942 |
| 79 | metallo-sulfur cluster assembly (GO:0031163) | 2.66383932 |
| 80 | iron-sulfur cluster assembly (GO:0016226) | 2.66383932 |
| 81 | positive regulation of lymphocyte migration (GO:2000403) | 2.64013666 |
| 82 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.62828597 |
| 83 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.59016057 |
| 84 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.58189670 |
| 85 | cytokine metabolic process (GO:0042107) | 2.57994490 |
| 86 | lymphocyte migration (GO:0072676) | 2.57417705 |
| 87 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.56717549 |
| 88 | negative regulation of ligase activity (GO:0051352) | 2.56705737 |
| 89 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.56705737 |
| 90 | positive regulation of interleukin-1 beta production (GO:0032731) | 2.56346749 |
| 91 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.54895725 |
| 92 | lymph node development (GO:0048535) | 2.53919780 |
| 93 | leukocyte apoptotic process (GO:0071887) | 2.52602578 |
| 94 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.51569728 |
| 95 | regulation of osteoclast differentiation (GO:0045670) | 2.51176021 |
| 96 | positive regulation of T cell mediated immunity (GO:0002711) | 2.50134016 |
| 97 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 11.8284680 |
| 98 | cytidine metabolic process (GO:0046087) | 11.0327678 |
| 99 | cytidine catabolic process (GO:0006216) | 11.0327678 |
| 100 | cytidine deamination (GO:0009972) | 11.0327678 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.72571849 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.16138405 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.93023619 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.75557589 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.43023393 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.19588682 |
| 7 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.06987813 |
| 8 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.95456184 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.84005966 |
| 10 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.77461536 |
| 11 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.68698589 |
| 12 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.66682997 |
| 13 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.54233587 |
| 14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.22743884 |
| 15 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.19750944 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.14579945 |
| 17 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.12911489 |
| 18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.11708078 |
| 19 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.06459830 |
| 20 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.04384199 |
| 21 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 10.3667677 |
| 22 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94050242 |
| 23 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.91622661 |
| 24 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.86928354 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 1.83210685 |
| 26 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.82781265 |
| 27 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.82535202 |
| 28 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.76079666 |
| 29 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.75571629 |
| 30 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.74065183 |
| 31 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.66391347 |
| 32 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.65493828 |
| 33 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.62219850 |
| 34 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.61764477 |
| 35 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.60999916 |
| 36 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.56930385 |
| 37 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.52743836 |
| 38 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.46715403 |
| 39 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.44460932 |
| 40 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.43486634 |
| 41 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.43369672 |
| 42 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.38618819 |
| 43 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.37179021 |
| 44 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.31148919 |
| 45 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.30376021 |
| 46 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.30066501 |
| 47 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.30009196 |
| 48 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.28321249 |
| 49 | MYB_26560356_Chip-Seq_TH1_Human | 1.26130239 |
| 50 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.24666631 |
| 51 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.23850059 |
| 52 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.22673181 |
| 53 | MAF_26560356_Chip-Seq_TH1_Human | 1.17228227 |
| 54 | GATA3_26560356_Chip-Seq_TH2_Human | 1.16581638 |
| 55 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14020196 |
| 56 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.13345102 |
| 57 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10046275 |
| 58 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.06965338 |
| 59 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.06105801 |
| 60 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.05452287 |
| 61 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.03635770 |
| 62 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.03486585 |
| 63 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.03485513 |
| 64 | MAF_26560356_Chip-Seq_TH2_Human | 1.01695786 |
| 65 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.01380172 |
| 66 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00663327 |
| 67 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00533162 |
| 68 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.99957454 |
| 69 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.98098772 |
| 70 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.97603788 |
| 71 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.96995281 |
| 72 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.96268120 |
| 73 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.96095075 |
| 74 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.91208403 |
| 75 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.91190438 |
| 76 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.88809484 |
| 77 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.87609024 |
| 78 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.87505004 |
| 79 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.86617539 |
| 80 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.85310437 |
| 81 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.84962483 |
| 82 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.84604857 |
| 83 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.84188446 |
| 84 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.83244798 |
| 85 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.81395515 |
| 86 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80662979 |
| 87 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.80548850 |
| 88 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.80269174 |
| 89 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.79802147 |
| 90 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.79132957 |
| 91 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.79132957 |
| 92 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.78468237 |
| 93 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.77958897 |
| 94 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75724212 |
| 95 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.75710359 |
| 96 | VDR_22108803_ChIP-Seq_LS180_Human | 0.74238198 |
| 97 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.73443595 |
| 98 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.72918072 |
| 99 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.71614755 |
| 100 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.70836043 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009785_altered_susceptibility_to | 4.89926676 |
| 2 | MP0005671_abnormal_response_to | 4.61401765 |
| 3 | MP0005387_immune_system_phenotype | 4.57660367 |
| 4 | MP0001790_abnormal_immune_system | 4.57660367 |
| 5 | MP0002933_joint_inflammation | 4.13699844 |
| 6 | MP0003436_decreased_susceptibility_to | 4.04970781 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 3.42301216 |
| 8 | MP0006082_CNS_inflammation | 3.24453264 |
| 9 | MP0001835_abnormal_antigen_presentation | 3.00330681 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.96507267 |
| 11 | MP0001800_abnormal_humoral_immune | 2.80594907 |
| 12 | MP0001849_ear_inflammation | 2.78688407 |
| 13 | MP0001853_heart_inflammation | 2.68804341 |
| 14 | MP0010155_abnormal_intestine_physiology | 2.66114665 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.62662759 |
| 16 | MP0002723_abnormal_immune_serum | 2.36807073 |
| 17 | MP0009333_abnormal_splenocyte_physiolog | 2.30921966 |
| 18 | MP0005025_abnormal_response_to | 2.26853634 |
| 19 | MP0001873_stomach_inflammation | 2.24989098 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.09356101 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.01501981 |
| 22 | MP0001819_abnormal_immune_cell | 1.98039767 |
| 23 | MP0002277_abnormal_respiratory_mucosa | 1.97795088 |
| 24 | MP0001533_abnormal_skeleton_physiology | 1.91597291 |
| 25 | MP0000685_abnormal_immune_system | 1.81819693 |
| 26 | MP0002095_abnormal_skin_pigmentation | 1.76762830 |
| 27 | MP0002405_respiratory_system_inflammati | 1.74125076 |
| 28 | MP0005310_abnormal_salivary_gland | 1.74117053 |
| 29 | MP0003448_altered_tumor_morphology | 1.69402424 |
| 30 | MP0003763_abnormal_thymus_physiology | 1.56672344 |
| 31 | MP0002876_abnormal_thyroid_physiology | 1.53736587 |
| 32 | MP0001845_abnormal_inflammatory_respons | 1.48061278 |
| 33 | MP0008873_increased_physiological_sensi | 1.47822622 |
| 34 | MP0002138_abnormal_hepatobiliary_system | 1.47395350 |
| 35 | MP0000716_abnormal_immune_system | 1.47354586 |
| 36 | MP0001243_abnormal_dermal_layer | 1.45949729 |
| 37 | MP0005187_abnormal_penis_morphology | 1.32455536 |
| 38 | MP0002722_abnormal_immune_system | 1.29685262 |
| 39 | MP0003045_fibrosis | 1.29596967 |
| 40 | MP0004947_skin_inflammation | 1.28877930 |
| 41 | MP0008469_abnormal_protein_level | 1.23892931 |
| 42 | MP0008438_abnormal_cutaneous_collagen | 1.22106443 |
| 43 | MP0002429_abnormal_blood_cell | 1.20620326 |
| 44 | MP0002419_abnormal_innate_immunity | 1.18766524 |
| 45 | MP0004145_abnormal_muscle_electrophysio | 1.18677358 |
| 46 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.18579014 |
| 47 | MP0002398_abnormal_bone_marrow | 1.17376545 |
| 48 | MP0002163_abnormal_gland_morphology | 1.14866470 |
| 49 | MP0001958_emphysema | 1.12435466 |
| 50 | MP0002998_abnormal_bone_remodeling | 1.08102626 |
| 51 | MP0005390_skeleton_phenotype | 1.07761854 |
| 52 | MP0005623_abnormal_meninges_morphology | 1.07197388 |
| 53 | MP0000703_abnormal_thymus_morphology | 1.05809827 |
| 54 | MP0005165_increased_susceptibility_to | 1.05244316 |
| 55 | MP0000689_abnormal_spleen_morphology | 1.05005272 |
| 56 | MP0000647_abnormal_sebaceous_gland | 1.03882134 |
| 57 | MP0003866_abnormal_defecation | 1.01612157 |
| 58 | MP0005319_abnormal_enzyme/_coenzyme | 0.97928639 |
| 59 | MP0001348_abnormal_lacrimal_gland | 0.97184921 |
| 60 | MP0000372_irregular_coat_pigmentation | 0.93628091 |
| 61 | MP0000343_altered_response_to | 0.93120950 |
| 62 | MP0003724_increased_susceptibility_to | 0.92614734 |
| 63 | MP0003786_premature_aging | 0.90776464 |
| 64 | MP0004510_myositis | 0.88489585 |
| 65 | MP0004134_abnormal_chest_morphology | 0.87962190 |
| 66 | MP0001765_abnormal_ion_homeostasis | 0.87636044 |
| 67 | MP0009763_increased_sensitivity_to | 0.84109843 |
| 68 | MP0003075_altered_response_to | 0.82433563 |
| 69 | MP0001542_abnormal_bone_strength | 0.78837193 |
| 70 | MP0001764_abnormal_homeostasis | 0.76830169 |
| 71 | MP0006036_abnormal_mitochondrial_physio | 0.76663895 |
| 72 | MP0002090_abnormal_vision | 0.74442892 |
| 73 | MP0003195_calcinosis | 0.74118433 |
| 74 | MP0000015_abnormal_ear_pigmentation | 0.73030125 |
| 75 | MP0002166_altered_tumor_susceptibility | 0.72256104 |
| 76 | MP0005636_abnormal_mineral_homeostasis | 0.71157912 |
| 77 | MP0006035_abnormal_mitochondrial_morpho | 0.69472031 |
| 78 | MP0009764_decreased_sensitivity_to | 0.69071635 |
| 79 | MP0000490_abnormal_crypts_of | 0.68572687 |
| 80 | MP0002254_reproductive_system_inflammat | 0.67303001 |
| 81 | MP0002877_abnormal_melanocyte_morpholog | 0.63622714 |
| 82 | MP0009765_abnormal_xenobiotic_induced | 0.62245048 |
| 83 | MP0000627_abnormal_mammary_gland | 0.62178045 |
| 84 | MP0003252_abnormal_bile_duct | 0.61280235 |
| 85 | MP0010307_abnormal_tumor_latency | 0.58656010 |
| 86 | MP0001346_abnormal_lacrimal_gland | 0.58254247 |
| 87 | MP0003186_abnormal_redox_activity | 0.56472341 |
| 88 | MP0002006_tumorigenesis | 0.55929695 |
| 89 | MP0003279_aneurysm | 0.54954273 |
| 90 | MP0002693_abnormal_pancreas_physiology | 0.54355216 |
| 91 | MP0001529_abnormal_vocalization | 0.53781716 |
| 92 | MP0004782_abnormal_surfactant_physiolog | 0.52459580 |
| 93 | MP0001663_abnormal_digestive_system | 0.52280180 |
| 94 | MP0005464_abnormal_platelet_physiology | 0.51882544 |
| 95 | MP0001191_abnormal_skin_condition | 0.51446697 |
| 96 | MP0003806_abnormal_nucleotide_metabolis | 0.50009782 |
| 97 | MP0003795_abnormal_bone_structure | 0.49747510 |
| 98 | MP0001661_extended_life_span | 0.49474160 |
| 99 | MP0000681_abnormal_thyroid_gland | 0.48240501 |
| 100 | MP0000604_amyloidosis | 0.47600442 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Renal Fanconi syndrome (HP:0001994) | 5.58859334 |
| 2 | Increased hepatocellular lipid droplets (HP:0006565) | 5.49260704 |
| 3 | Periodontitis (HP:0000704) | 5.25973171 |
| 4 | Chronic mucocutaneous candidiasis (HP:0002728) | 5.01817786 |
| 5 | Recurrent cutaneous fungal infections (HP:0011370) | 5.01817786 |
| 6 | Lipid accumulation in hepatocytes (HP:0006561) | 5.01653415 |
| 7 | Increased intramyocellular lipid droplets (HP:0012240) | 4.90620953 |
| 8 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.65788744 |
| 9 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.65788744 |
| 10 | Increased muscle lipid content (HP:0009058) | 4.20246048 |
| 11 | Median cleft lip (HP:0000161) | 4.16200672 |
| 12 | Abnormality of T cell number (HP:0011839) | 4.09919657 |
| 13 | T lymphocytopenia (HP:0005403) | 3.93974609 |
| 14 | Hemoptysis (HP:0002105) | 3.71087191 |
| 15 | Premature loss of primary teeth (HP:0006323) | 3.64263859 |
| 16 | Exertional dyspnea (HP:0002875) | 3.61601261 |
| 17 | Abnormality of T cells (HP:0002843) | 3.61218909 |
| 18 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.51022388 |
| 19 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.41810340 |
| 20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.37351161 |
| 21 | Keratoconjunctivitis (HP:0001096) | 3.35854386 |
| 22 | Abnormality of renal resorption (HP:0011038) | 3.34090109 |
| 23 | Keratoconjunctivitis sicca (HP:0001097) | 3.33599902 |
| 24 | Cheilitis (HP:0100825) | 3.28547579 |
| 25 | IgA deficiency (HP:0002720) | 3.26322735 |
| 26 | Chronic diarrhea (HP:0002028) | 3.17648410 |
| 27 | Autoimmune hemolytic anemia (HP:0001890) | 3.17509922 |
| 28 | Recurrent fungal infections (HP:0002841) | 3.10167677 |
| 29 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.08347693 |
| 30 | Abnormality of T cell physiology (HP:0011840) | 3.08293097 |
| 31 | Hepatosplenomegaly (HP:0001433) | 3.04834636 |
| 32 | Autoimmune thrombocytopenia (HP:0001973) | 3.03527889 |
| 33 | Generalized aminoaciduria (HP:0002909) | 3.02968564 |
| 34 | Malignant hyperthermia (HP:0002047) | 3.00512811 |
| 35 | Retrobulbar optic neuritis (HP:0100654) | 2.99712269 |
| 36 | Optic neuritis (HP:0100653) | 2.99712269 |
| 37 | Orchitis (HP:0100796) | 2.96071164 |
| 38 | Mitochondrial inheritance (HP:0001427) | 2.92178488 |
| 39 | Increased IgM level (HP:0003496) | 2.85498465 |
| 40 | IgG deficiency (HP:0004315) | 2.78065223 |
| 41 | Increased CSF lactate (HP:0002490) | 2.78013307 |
| 42 | Abnormality of the pleura (HP:0002103) | 2.70542023 |
| 43 | Myositis (HP:0100614) | 2.68229014 |
| 44 | Pulmonary infiltrates (HP:0002113) | 2.67675694 |
| 45 | Loss of speech (HP:0002371) | 2.66668454 |
| 46 | 11 pairs of ribs (HP:0000878) | 2.54206218 |
| 47 | Respiratory difficulties (HP:0002880) | 2.53548175 |
| 48 | IgM deficiency (HP:0002850) | 2.47841199 |
| 49 | Abnormality of urine glucose concentration (HP:0011016) | 2.45756252 |
| 50 | Glycosuria (HP:0003076) | 2.45756252 |
| 51 | Poor head control (HP:0002421) | 2.41028857 |
| 52 | Skin rash (HP:0000988) | 2.40603096 |
| 53 | Stomatitis (HP:0010280) | 2.40280079 |
| 54 | Lower limb hyperreflexia (HP:0002395) | 2.36228126 |
| 55 | Meningitis (HP:0001287) | 2.34537690 |
| 56 | Abnormality of macrophages (HP:0004311) | 2.34421314 |
| 57 | Hypoproteinemia (HP:0003075) | 2.33384942 |
| 58 | Joint swelling (HP:0001386) | 2.31655615 |
| 59 | Encephalitis (HP:0002383) | 2.31046412 |
| 60 | Porencephaly (HP:0002132) | 2.30201417 |
| 61 | Acute necrotizing encephalopathy (HP:0006965) | 2.29910584 |
| 62 | Ureteral stenosis (HP:0000071) | 2.29735926 |
| 63 | Gangrene (HP:0100758) | 2.25607533 |
| 64 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.24451795 |
| 65 | Aplastic anemia (HP:0001915) | 2.23894832 |
| 66 | Abnormality of the prostate (HP:0008775) | 2.18431913 |
| 67 | Vasculitis (HP:0002633) | 2.15418192 |
| 68 | Abnormality of eosinophils (HP:0001879) | 2.15399374 |
| 69 | 3-Methylglutaconic aciduria (HP:0003535) | 2.09663061 |
| 70 | Chronic obstructive pulmonary disease (HP:0006510) | 2.08543955 |
| 71 | Obstructive lung disease (HP:0006536) | 2.08543955 |
| 72 | Bifid uvula (HP:0000193) | 2.08484619 |
| 73 | Postaxial foot polydactyly (HP:0001830) | 2.08351651 |
| 74 | Hyperphosphaturia (HP:0003109) | 2.08303309 |
| 75 | Ureteral obstruction (HP:0006000) | 2.05104971 |
| 76 | Progressive inability to walk (HP:0002505) | 2.03670963 |
| 77 | Mild short stature (HP:0003502) | 2.03605672 |
| 78 | Episodic fever (HP:0001954) | 2.02170286 |
| 79 | Increased serum lactate (HP:0002151) | 2.01051581 |
| 80 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.00895537 |
| 81 | Recurrent bronchitis (HP:0002837) | 2.00655996 |
| 82 | Lactic acidosis (HP:0003128) | 2.00184278 |
| 83 | Abnormal foot bone ossification (HP:0010675) | 1.97600115 |
| 84 | Recurrent skin infections (HP:0001581) | 1.92846315 |
| 85 | Severe combined immunodeficiency (HP:0004430) | 1.92412077 |
| 86 | Exercise intolerance (HP:0003546) | 1.91924554 |
| 87 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.90090561 |
| 88 | Increased cerebral lipofuscin (HP:0011813) | 1.89532042 |
| 89 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.89200676 |
| 90 | Abnormal number of incisors (HP:0011064) | 1.89177030 |
| 91 | Panhypogammaglobulinemia (HP:0003139) | 1.87726139 |
| 92 | Abnormality of the pericardium (HP:0001697) | 1.86428652 |
| 93 | Stillbirth (HP:0003826) | 1.86149144 |
| 94 | Lymphopenia (HP:0001888) | 1.81168810 |
| 95 | Short tibia (HP:0005736) | 1.80006182 |
| 96 | Cleft eyelid (HP:0000625) | 1.79940995 |
| 97 | Carpal bone hypoplasia (HP:0001498) | 1.79559295 |
| 98 | Recurrent viral infections (HP:0004429) | 1.79122779 |
| 99 | Progressive macrocephaly (HP:0004481) | 1.78630070 |
| 100 | Cerebral edema (HP:0002181) | 1.75375933 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.46040783 |
| 2 | NEK1 | 4.80079658 |
| 3 | BCKDK | 4.76862425 |
| 4 | TLK1 | 3.03844402 |
| 5 | ACVR1B | 2.67909562 |
| 6 | WNK4 | 2.66594263 |
| 7 | CLK1 | 2.62240895 |
| 8 | STK39 | 2.60614263 |
| 9 | EIF2AK1 | 2.48423702 |
| 10 | KDR | 2.37444850 |
| 11 | MAP2K6 | 2.28327126 |
| 12 | VRK1 | 2.28118764 |
| 13 | PRKD3 | 2.12240975 |
| 14 | ITK | 2.12165172 |
| 15 | EIF2AK3 | 2.05286312 |
| 16 | OXSR1 | 1.98027669 |
| 17 | MAP4K1 | 1.69961094 |
| 18 | CSF1R | 1.69647052 |
| 19 | MST4 | 1.63913782 |
| 20 | NME2 | 1.53872129 |
| 21 | PIK3CA | 1.52381966 |
| 22 | IKBKB | 1.48636988 |
| 23 | JAK3 | 1.43919675 |
| 24 | NEK9 | 1.42286195 |
| 25 | VRK2 | 1.41683858 |
| 26 | TAOK3 | 1.41145607 |
| 27 | PRKCH | 1.33031989 |
| 28 | DAPK3 | 1.20588803 |
| 29 | STK16 | 1.17758868 |
| 30 | MATK | 1.12137088 |
| 31 | MYLK | 1.08723875 |
| 32 | ADRBK2 | 1.07641800 |
| 33 | NUAK1 | 1.07164684 |
| 34 | LCK | 1.03491976 |
| 35 | MAP3K14 | 1.01465413 |
| 36 | ERN1 | 1.00137378 |
| 37 | TYK2 | 0.99947914 |
| 38 | SYK | 0.97342707 |
| 39 | TNK2 | 0.91985522 |
| 40 | CCNB1 | 0.91873994 |
| 41 | MAP3K13 | 0.87795335 |
| 42 | PRKCQ | 0.84123756 |
| 43 | DAPK1 | 0.77395199 |
| 44 | GRK7 | 0.75919043 |
| 45 | ZAK | 0.72523870 |
| 46 | LIMK1 | 0.71502350 |
| 47 | MAP3K3 | 0.70134324 |
| 48 | CSK | 0.67129250 |
| 49 | PIK3CG | 0.66201679 |
| 50 | CAMKK2 | 0.65375937 |
| 51 | EPHA4 | 0.62791448 |
| 52 | RIPK4 | 0.61700617 |
| 53 | NTRK1 | 0.61437328 |
| 54 | IKBKE | 0.57790603 |
| 55 | EPHA3 | 0.57668489 |
| 56 | PHKG1 | 0.56769973 |
| 57 | PHKG2 | 0.56769973 |
| 58 | CHUK | 0.56203748 |
| 59 | TESK2 | 0.55169941 |
| 60 | LYN | 0.51522476 |
| 61 | AURKA | 0.51381752 |
| 62 | BCR | 0.50038052 |
| 63 | ABL2 | 0.49938970 |
| 64 | ATR | 0.49260872 |
| 65 | GRK1 | 0.49117023 |
| 66 | PLK3 | 0.47686688 |
| 67 | CDK15 | 0.47600927 |
| 68 | CDK18 | 0.45919295 |
| 69 | JAK1 | 0.45733695 |
| 70 | BMPR2 | 0.45686475 |
| 71 | PRKCD | 0.44426181 |
| 72 | MAP3K12 | 0.43078809 |
| 73 | CDK11A | 0.40352900 |
| 74 | KIT | 0.39962934 |
| 75 | BUB1 | 0.39909421 |
| 76 | JAK2 | 0.39119090 |
| 77 | PRKG2 | 0.38989774 |
| 78 | CAMK2D | 0.38981425 |
| 79 | FGFR1 | 0.37737728 |
| 80 | PRKCE | 0.36503222 |
| 81 | STK10 | 0.36048701 |
| 82 | HIPK2 | 0.35256820 |
| 83 | TBK1 | 0.34340576 |
| 84 | RPS6KA6 | 0.32072814 |
| 85 | CSNK2A1 | 0.32018114 |
| 86 | MAPKAPK5 | 0.30827471 |
| 87 | ILK | 0.30520138 |
| 88 | WNK1 | 0.30341600 |
| 89 | CDK14 | 0.30001460 |
| 90 | PRKCA | 0.29945887 |
| 91 | MAP4K2 | 0.28304274 |
| 92 | RPS6KC1 | 0.28282026 |
| 93 | RPS6KL1 | 0.28282026 |
| 94 | MAPKAPK3 | 0.27919268 |
| 95 | ADRBK1 | 0.26990172 |
| 96 | ROCK1 | 0.26900599 |
| 97 | MAPKAPK2 | 0.26540905 |
| 98 | IGF1R | 0.26443860 |
| 99 | FYN | 0.26307585 |
| 100 | TTK | 0.25798995 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 5.30183041 |
| 2 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 4.14298259 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.88268143 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.83657007 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.73878947 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 3.54445339 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.30695136 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.71221108 |
| 9 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.57383438 |
| 10 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 2.54136699 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.53741561 |
| 12 | Protein export_Homo sapiens_hsa03060 | 2.53101694 |
| 13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.96776692 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.87447976 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.85292661 |
| 16 | Parkinsons disease_Homo sapiens_hsa05012 | 1.84661496 |
| 17 | RNA polymerase_Homo sapiens_hsa03020 | 1.80663309 |
| 18 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.70740287 |
| 19 | Measles_Homo sapiens_hsa05162 | 1.61957313 |
| 20 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.42992164 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.41677235 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.38422153 |
| 23 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.37587803 |
| 24 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.32870716 |
| 25 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.25807119 |
| 26 | Homologous recombination_Homo sapiens_hsa03440 | 1.20591811 |
| 27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.16633360 |
| 28 | Ribosome_Homo sapiens_hsa03010 | 1.14055090 |
| 29 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.11380382 |
| 30 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.11336990 |
| 31 | Huntingtons disease_Homo sapiens_hsa05016 | 1.08001504 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.07610358 |
| 33 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.02731458 |
| 34 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.99225968 |
| 35 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.95501625 |
| 36 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.94786242 |
| 37 | Alzheimers disease_Homo sapiens_hsa05010 | 0.94653792 |
| 38 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.92261865 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.91654693 |
| 40 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.91436815 |
| 41 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.89956179 |
| 42 | Mismatch repair_Homo sapiens_hsa03430 | 0.89497980 |
| 43 | DNA replication_Homo sapiens_hsa03030 | 0.86448396 |
| 44 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.86336761 |
| 45 | Apoptosis_Homo sapiens_hsa04210 | 0.81674224 |
| 46 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.77076686 |
| 47 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.73441984 |
| 48 | Leishmaniasis_Homo sapiens_hsa05140 | 0.72634208 |
| 49 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.71808335 |
| 50 | Viral myocarditis_Homo sapiens_hsa05416 | 0.70105364 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.66255800 |
| 52 | Purine metabolism_Homo sapiens_hsa00230 | 0.60613252 |
| 53 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.59597139 |
| 54 | Peroxisome_Homo sapiens_hsa04146 | 0.56932904 |
| 55 | Influenza A_Homo sapiens_hsa05164 | 0.56658213 |
| 56 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.54210243 |
| 57 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.52783073 |
| 58 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.50912783 |
| 59 | Lysosome_Homo sapiens_hsa04142 | 0.50687126 |
| 60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48899167 |
| 61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.48616754 |
| 62 | Phototransduction_Homo sapiens_hsa04744 | 0.47885579 |
| 63 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.47533995 |
| 64 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.47166071 |
| 65 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.42359997 |
| 66 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.42245425 |
| 67 | Sulfur relay system_Homo sapiens_hsa04122 | 0.41690751 |
| 68 | HTLV-I infection_Homo sapiens_hsa05166 | 0.41602409 |
| 69 | Salmonella infection_Homo sapiens_hsa05132 | 0.41230174 |
| 70 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.39944289 |
| 71 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.39841280 |
| 72 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.39497287 |
| 73 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.36516995 |
| 74 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.36461712 |
| 75 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.35427365 |
| 76 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.34716950 |
| 77 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.33752701 |
| 78 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.33425229 |
| 79 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.32801152 |
| 80 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.31131352 |
| 81 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.30276810 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30066358 |
| 83 | RNA degradation_Homo sapiens_hsa03018 | 0.29617573 |
| 84 | Pertussis_Homo sapiens_hsa05133 | 0.29497542 |
| 85 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.29304780 |
| 86 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.28292609 |
| 87 | Hepatitis C_Homo sapiens_hsa05160 | 0.28059828 |
| 88 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28059319 |
| 89 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.25397786 |
| 90 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.25219570 |
| 91 | Mineral absorption_Homo sapiens_hsa04978 | 0.25016685 |
| 92 | Spliceosome_Homo sapiens_hsa03040 | 0.24148590 |
| 93 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.23557212 |
| 94 | Alcoholism_Homo sapiens_hsa05034 | 0.22958027 |
| 95 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.22348473 |
| 96 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.22098922 |
| 97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.19108319 |
| 98 | Tuberculosis_Homo sapiens_hsa05152 | 0.18968975 |
| 99 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.15748350 |
| 100 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.12745007 |

